Man Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-965,093
| Closed | -$98M | – | 2450 |
|
|
2025
Q4 | $98M | Buy |
965,093
+936,071
| +3,225% | +$75.2M | 0.17% | 141 |
|
|
2025
Q3 | $1.59M | Sell |
29,022
-454,187
| -94% | -$22.7M | ﹤0.01% | 1513 |
|
|
2025
Q2 | $25.7M | Buy |
483,209
+355,165
| +277% | +$18M | 0.05% | 415 |
|
|
2025
Q1 | $5.54M | Buy |
128,044
+68,042
| +113% | +$3.45M | 0.01% | 980 |
|
|
2024
Q4 | $3.37M | Buy |
+60,002
| New | +$3.73M | 0.01% | 1155 |
|
|
2024
Q3 | – | Sell |
-13,539
| Closed | -$572K | – | 2035 |
|
|
2024
Q2 | $572K | Sell |
13,539
-79,410
| -85% | -$4.37M | ﹤0.01% | 1654 |
|
|
2024
Q1 | $6.42M | Sell |
92,949
-226,130
| -71% | -$14.3M | 0.02% | 888 |
|
|
2023
Q4 | $23.6M | Buy |
+319,079
| New | +$20.9M | 0.07% | 346 |
|
|
2023
Q3 | – | Sell |
-320,798
| Closed | -$27.2M | – | 274 |
|
|
2023
Q2 | $30.1M | Buy |
+320,798
| New | +$25M | 0.09% | 265 |
|
|
2023
Q1 | – | Sell |
-296,227
| Closed | -$19M | – | 751 |
|
|
2022
Q4 | $14.7M | Buy |
296,227
+139,086
| +89% | +$5.68M | 0.05% | 427 |
|
|
2022
Q3 | $5.11M | Buy |
+157,141
| New | +$6.48M | 0.02% | 730 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1618 |
|
|
2022
Q1 | – | Sell |
-11,238
| Closed | -$875K | – | 2219 |
|
|
2021
Q4 | $875K | Sell |
11,238
-39,419
| -78% | -$3.48M | ﹤0.01% | 1364 |
|
|
2021
Q3 | $4.83M | Buy |
50,657
+21,992
| +77% | +$2.32M | 0.02% | 851 |
|
|
2021
Q2 | $3.56M | Buy |
28,665
+26,807
| +1,443% | +$3.2M | 0.01% | 1024 |
|
|
2021
Q1 | $245K | Sell |
1,858
-17,801
| -91% | -$2.44M | ﹤0.01% | 1688 |
|
|
2020
Q4 | $2.6M | Sell |
19,659
-4,874
| -20% | -$589K | 0.01% | 1103 |
|
|
2020
Q3 | $2.5M | Sell |
24,533
-23,895
| -49% | -$2.06M | 0.01% | 1118 |
|
|
2020
Q2 | $4.21M | Buy |
48,428
+43,875
| +964% | +$3.51M | 0.02% | 753 |
|
|
2020
Q1 | $264K | Buy |
4,553
+1,881
| +70% | +$153K | ﹤0.01% | 1412 |
|
|
2019
Q4 | $247K | Buy |
+2,672
| New | +$235K | ﹤0.01% | 1715 |
|
|
2019
Q2 | – | Sell |
-21,257
| Closed | -$1.84M | – | 1920 |
|
|
2019
Q1 | $1.84M | Buy |
21,257
+13,186
| +163% | +$1.12M | 0.01% | 1368 |
|
|
2018
Q4 | $509K | Sell |
8,071
-1,153
| -13% | -$79.1K | ﹤0.01% | 1623 |
|
|
2018
Q3 | $728K | Buy |
+9,224
| New | +$601K | ﹤0.01% | 1761 |
|
|
2018
Q2 | – | Sell |
-10,933
| Closed | -$441K | – | 2145 |
|
|
2018
Q1 | $441K | Buy |
+10,933
| New | +$533K | ﹤0.01% | 1749 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Man Group's EXAS Position: Q1 2026 in Review
Man Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 965,093 shares — an estimated $98M sold.
Man Group first reported a position in EXAS in Q1 2018 and held it in 24 quarters. The position peaked at $98M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Man Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Man Group sold 965,093 Exact Sciences shares in Q1 2026, an estimated $98M.
- Man Group first reported a position in Exact Sciences in Q1 2018 and held it in 24 quarters.
- Man Group's Exact Sciences position peaked at $98M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.